Suppr超能文献

血管平滑肌细胞中 BAF60a 的缺乏通过减少炎症和细胞外基质降解来预防腹主动脉瘤。

BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix Degradation.

机构信息

Department of Internal Medicine, Frankel Cardiovascular Center (Z.C., G.Z., Y.Z., H.L., W.X., W.L., J.S., H.W., T.Z., O.R., Y.G., Y.F., L.C., M.T.G.-B., Y.E.C., J.Z.), University of Michigan Medical Center, Ann Arbor.

Department of Metabolism and Endocrinology (Z.C.), The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.

出版信息

Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2494-2507. doi: 10.1161/ATVBAHA.120.314955. Epub 2020 Aug 13.

Abstract

OBJECTIVE

Currently, there are no approved drugs for abdominal aortic aneurysm (AAA) treatment, likely due to limited understanding of the primary molecular mechanisms underlying AAA development and progression. BAF60a-a unique subunit of the SWI/SNF (switch/sucrose nonfermentable) chromatin remodeling complex-is a novel regulator of metabolic homeostasis, yet little is known about its function in the vasculature and pathogenesis of AAA. In this study, we sought to investigate the role and underlying mechanisms of vascular smooth muscle cell (VSMC)-specific BAF60a in AAA formation. Approach and Results: BAF60a is upregulated in human and experimental murine AAA lesions. In vivo studies revealed that VSMC-specific knockout of BAF60a protected mice from both Ang II (angiotensin II)-induced and elastase-induced AAA formation with significant suppression of vascular inflammation, monocyte infiltration, and elastin fragmentation. Through RNA sequencing and pathway analysis, we found that the expression of inflammatory response genes in cultured human aortic smooth muscle cells was significantly downregulated by small interfering RNA-mediated BAF60a knockdown while upregulated upon adenovirus-mediated BAF60a overexpression. BAF60a regulates VSMC inflammation by recruiting BRG1 (Brahma-related gene-1)-a catalytic subunit of the SWI/SNF complex-to the promoter region of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) target genes. Furthermore, loss of BAF60a in VSMCs prevented the upregulation of the proteolytic enzyme cysteine protease CTSS (cathepsin S), thus ameliorating ECM (extracellular matrix) degradation within the vascular wall in AAA.

CONCLUSIONS

Our study demonstrated that BAF60a is required to recruit the SWI/SNF complex to facilitate the epigenetic regulation of VSMC inflammation, which may serve as a potential therapeutic target in preventing and treating AAA.

摘要

目的

目前尚无治疗腹主动脉瘤(AAA)的批准药物,这可能是由于对 AAA 发展和进展的主要分子机制了解有限。BAF60a-一种独特的 SWI/SNF(转换/蔗糖非发酵)染色质重塑复合物亚基-是代谢稳态的新型调节剂,但它在血管中的功能及其在 AAA 发病机制中的作用知之甚少。在这项研究中,我们试图研究血管平滑肌细胞(VSMC)特异性 BAF60a 在 AAA 形成中的作用和潜在机制。

方法和结果

BAF60a 在人及实验性鼠 AAA 病变中上调。体内研究表明,血管平滑肌细胞特异性 BAF60a 敲除可保护小鼠免受 Ang II(血管紧张素 II)诱导和弹性蛋白酶诱导的 AAA 形成,同时显著抑制血管炎症、单核细胞浸润和弹性蛋白片段化。通过 RNA 测序和通路分析,我们发现,在培养的人主动脉平滑肌细胞中,小干扰 RNA 介导的 BAF60a 敲低显著下调炎症反应基因的表达,而腺病毒介导的 BAF60a 过表达则上调。BAF60a 通过将 BRG1(SWI/SNF 复合物的催化亚基)募集到 NF-κB(核因子 kappa-轻链增强子的激活 B 细胞)靶基因的启动子区域,调节 VSMC 炎症。此外,VSMCs 中 BAF60a 的缺失阻止了蛋白水解酶半胱氨酸蛋白酶 CTSS(组织蛋白酶 S)的上调,从而改善 AAA 血管壁内 ECM(细胞外基质)降解。

结论

我们的研究表明,BAF60a 是募集 SWI/SNF 复合物以促进 VSMC 炎症的表观遗传调节所必需的,这可能成为预防和治疗 AAA 的潜在治疗靶点。

相似文献

1
BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix Degradation.
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2494-2507. doi: 10.1161/ATVBAHA.120.314955. Epub 2020 Aug 13.
3
Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation.
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):331-345. doi: 10.1161/ATVBAHA.120.315398. Epub 2020 Nov 5.
4
Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2161-2170. doi: 10.1161/ATVBAHA.117.309768. Epub 2017 Sep 7.
6
Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm.
Circ Res. 2024 May 24;134(11):1495-1511. doi: 10.1161/CIRCRESAHA.124.324323. Epub 2024 Apr 30.
7
L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift.
Circ Res. 2024 Aug 2;135(4):488-502. doi: 10.1161/CIRCRESAHA.124.324366. Epub 2024 Jul 9.
8
Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms.
J Vasc Surg. 2010 Oct;52(4):984-93. doi: 10.1016/j.jvs.2010.05.089. Epub 2010 Jul 13.
9
Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm.
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2412-22. doi: 10.1161/ATVBAHA.115.305529. Epub 2015 Sep 3.
10
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Vascul Pharmacol. 2021 Feb;136:106818. doi: 10.1016/j.vph.2020.106818. Epub 2020 Nov 21.

引用本文的文献

1
Single-cell spatial transcriptomics unravels the cellular landscape of abdominal aortic aneurysm.
JCI Insight. 2025 Aug 22;10(16). doi: 10.1172/jci.insight.190534.
3
The multifaceted roles of BAF60 subunits in muscle: regulation of differentiation, reprogramming, and metabolic homeostasis.
Front Cell Dev Biol. 2025 Jun 26;13:1594423. doi: 10.3389/fcell.2025.1594423. eCollection 2025.
4
Aortic aneurysm: pathophysiology and therapeutic options.
MedComm (2020). 2024 Sep 7;5(9):e703. doi: 10.1002/mco2.703. eCollection 2024 Sep.
5
Glutamine Protects against Mouse Abdominal Aortic Aneurysm through Modulating VSMC Apoptosis and M1 Macrophage Activation.
Int J Med Sci. 2024 May 19;21(8):1414-1427. doi: 10.7150/ijms.96395. eCollection 2024.
6
Epigenetic modifications in abdominal aortic aneurysms: from basic to clinical.
Front Cardiovasc Med. 2024 Jun 4;11:1394889. doi: 10.3389/fcvm.2024.1394889. eCollection 2024.
10
Superfamily II helicases: the potential therapeutic target for cardiovascular diseases.
Front Cardiovasc Med. 2023 Dec 13;10:1309491. doi: 10.3389/fcvm.2023.1309491. eCollection 2023.

本文引用的文献

1
Cyclodextrin Prevents Abdominal Aortic Aneurysm via Activation of Vascular Smooth Muscle Cell Transcription Factor EB.
Circulation. 2020 Aug 4;142(5):483-498. doi: 10.1161/CIRCULATIONAHA.119.044803. Epub 2020 May 1.
2
Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers.
Nat Genet. 2019 Sep;51(9):1399-1410. doi: 10.1038/s41588-019-0477-9. Epub 2019 Aug 19.
3
Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation.
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1351-1368. doi: 10.1161/ATVBAHA.119.312787. Epub 2019 May 30.
4
Novel gene regulatory networks identified in response to nitro-conjugated linoleic acid in human endothelial cells.
Physiol Genomics. 2019 Jun 1;51(6):224-233. doi: 10.1152/physiolgenomics.00127.2018. Epub 2019 May 10.
5
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.
Nat Cell Biol. 2018 Dec;20(12):1410-1420. doi: 10.1038/s41556-018-0221-1. Epub 2018 Nov 5.
6
Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.
J Immunol Res. 2018 Jun 3;2018:7213760. doi: 10.1155/2018/7213760. eCollection 2018.
7
Cell‑specific histone modifications in atherosclerosis (Review).
Mol Med Rep. 2018 Aug;18(2):1215-1224. doi: 10.3892/mmr.2018.9142. Epub 2018 Jun 6.
9
Unspliced XBP1 Confers VSMC Homeostasis and Prevents Aortic Aneurysm Formation via FoxO4 Interaction.
Circ Res. 2017 Dec 8;121(12):1331-1345. doi: 10.1161/CIRCRESAHA.117.311450. Epub 2017 Oct 31.
10
The SWI/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control.
Protein Cell. 2018 Feb;9(2):207-215. doi: 10.1007/s13238-017-0442-2. Epub 2017 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验